J
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
Price:
26.75
CNY
-0.41%
Market Closed
Market Cap:
¥11.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
|
CN |
|
Kalyan Jewellers India Ltd
NSE:KALYANKJIL
|
IN |
|
A
|
APT Medical Inc
SSE:688617
|
CN |
|
Tegma Gestao Logistica SA
BOVESPA:TGMA3
|
BR |
Income Statement
Earnings Waterfall
JiangXi Tianxin Pharmaceutical Co Ltd
JiangXi Tianxin Pharmaceutical Co Ltd
Income Statement
JiangXi Tianxin Pharmaceutical Co Ltd
JiangXi Tianxin Pharmaceutical Co Ltd
Currency: CNY
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
13
|
7
|
5
|
0
|
7
|
0
|
1
|
0
|
2
|
0
|
2
|
0
|
2
|
0
|
0
|
0
|
|
| Revenue |
2 522
N/A
|
2 488
-1%
|
2 496
+0%
|
2 514
+1%
|
2 305
-8%
|
2 277
-1%
|
2 184
-4%
|
2 042
-7%
|
1 882
-8%
|
1 798
-4%
|
1 828
+2%
|
2 008
+10%
|
2 209
+10%
|
2 333
+6%
|
2 264
-3%
|
2 226
-2%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(1 432)
|
(1 435)
|
(1 479)
|
(1 514)
|
(1 450)
|
(1 505)
|
(1 450)
|
(1 354)
|
(1 174)
|
(1 083)
|
(1 094)
|
(1 172)
|
(1 288)
|
(1 317)
|
(1 272)
|
(1 268)
|
|
| Gross Profit |
1 090
N/A
|
1 053
-3%
|
1 017
-3%
|
1 000
-2%
|
855
-15%
|
771
-10%
|
735
-5%
|
687
-6%
|
708
+3%
|
715
+1%
|
734
+3%
|
836
+14%
|
921
+10%
|
1 016
+10%
|
992
-2%
|
958
-3%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(172)
|
(165)
|
(182)
|
(203)
|
(231)
|
(229)
|
(238)
|
(221)
|
(251)
|
(238)
|
(244)
|
(267)
|
(265)
|
(259)
|
(275)
|
(281)
|
|
| Selling, General & Administrative |
(163)
|
(157)
|
(164)
|
(179)
|
(186)
|
(178)
|
(170)
|
(170)
|
(176)
|
(161)
|
(167)
|
(171)
|
(192)
|
(192)
|
(199)
|
(203)
|
|
| Research & Development |
(57)
|
(61)
|
(70)
|
(77)
|
(86)
|
(89)
|
(91)
|
(91)
|
(100)
|
(119)
|
(119)
|
(122)
|
(91)
|
(102)
|
(101)
|
(102)
|
|
| Depreciation & Amortization |
(9)
|
(5)
|
(5)
|
0
|
(11)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
57
|
57
|
58
|
52
|
52
|
38
|
23
|
40
|
46
|
42
|
41
|
26
|
42
|
34
|
25
|
24
|
|
| Operating Income |
919
N/A
|
887
-3%
|
835
-6%
|
797
-5%
|
624
-22%
|
542
-13%
|
497
-8%
|
466
-6%
|
457
-2%
|
477
+5%
|
490
+3%
|
569
+16%
|
656
+15%
|
756
+15%
|
717
-5%
|
677
-6%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(42)
|
(44)
|
21
|
78
|
103
|
104
|
143
|
100
|
106
|
130
|
93
|
90
|
119
|
101
|
70
|
63
|
|
| Non-Reccuring Items |
(3)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
|
| Gain/Loss on Disposition of Assets |
1
|
(1)
|
(1)
|
0
|
(1)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
0
|
(1)
|
(0)
|
1
|
1
|
1
|
1
|
3
|
2
|
2
|
2
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
873
N/A
|
843
-4%
|
854
+1%
|
874
+2%
|
726
-17%
|
646
-11%
|
641
-1%
|
567
-12%
|
565
0%
|
610
+8%
|
584
-4%
|
661
+13%
|
772
+17%
|
856
+11%
|
786
-8%
|
738
-6%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(130)
|
(126)
|
(129)
|
(126)
|
(104)
|
(94)
|
(91)
|
(83)
|
(89)
|
(95)
|
(93)
|
(104)
|
(121)
|
(134)
|
(124)
|
(121)
|
|
| Income from Continuing Operations |
744
|
716
|
725
|
748
|
622
|
553
|
551
|
484
|
476
|
515
|
491
|
557
|
651
|
722
|
662
|
617
|
|
| Net Income (Common) |
744
N/A
|
716
-4%
|
725
+1%
|
748
+3%
|
622
-17%
|
553
-11%
|
551
0%
|
484
-12%
|
476
-2%
|
515
+8%
|
491
-5%
|
557
+14%
|
651
+17%
|
722
+11%
|
662
-8%
|
617
-7%
|
|
| EPS (Diluted) |
1.7
N/A
|
1.64
-4%
|
1.66
+1%
|
1.71
+3%
|
1.42
-17%
|
1.26
-11%
|
1.26
N/A
|
1.11
-12%
|
1.09
-2%
|
1.18
+8%
|
1.12
-5%
|
1.27
+13%
|
1.49
+17%
|
1.65
+11%
|
1.53
-7%
|
1.42
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
